Page last updated: 2024-11-05

zardaverine and Cancer of Skin

zardaverine has been researched along with Cancer of Skin in 1 studies

zardaverine: structure given in first source
zardaverine : A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nazir, M1
Senkowski, W1
Nyberg, F1
Blom, K1
Edqvist, PH1
Jarvius, M1
Andersson, C1
Gustafsson, MG1
Nygren, P1
Larsson, R1
Fryknäs, M1

Other Studies

1 other study available for zardaverine and Cancer of Skin

ArticleYear
Targeting tumor cells based on Phosphodiesterase 3A expression.
    Experimental cell research, 2017, 12-15, Volume: 361, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Carrier Proteins; Cell Line, Tumor; Colonic N

2017